Your browser doesn't support javascript.
loading
ATP1A3 as a target for isolating neuron-specific extracellular vesicles from human brain and biofluids.
You, Yang; Zhang, Zhengrong; Sultana, Nadia; Ericsson, Maria; Martens, Yuka A; Sun, Min; Kanekiyo, Takahisa; Ikezu, Seiko; Shaffer, Scott A; Ikezu, Tsuneya.
Affiliation
  • You Y; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Zhang Z; Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
  • Sultana N; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Ericsson M; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Martens YA; Mass Spectrometry Facility, University of Massachusetts Chan Medical School, Shrewsbury, MA USA.
  • Sun M; Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
  • Kanekiyo T; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Ikezu S; Nanoview Biosciences, Boston, MA, USA School, Boston, MA, USA.
  • Shaffer SA; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Ikezu T; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Sci Adv ; 9(37): eadi3647, 2023 09 15.
Article de En | MEDLINE | ID: mdl-37713494
ABSTRACT
Neuron-derived extracellular vesicles (NDEVs) are potential biomarkers of neurological diseases although their reliable molecular target is not well established. Here, we demonstrate that ATPase Na+/K+ transporting subunit alpha 3 (ATP1A3) is abundantly expressed in extracellular vesicles (EVs) isolated from induced human neuron, brain, cerebrospinal fluid, and plasma in comparison with the presumed NDEV markers NCAM1 and L1CAM by using super-resolution microscopy and biochemical assessments. Proteomic analysis of immunoprecipitated ATP1A3+ brain-derived EVs shows higher enrichment of synaptic markers and cargo proteins relevant to Alzheimer's disease (AD) compared to NCAM1+ or LICAM+ EVs. Single particle analysis shows the elevated amyloid-ß positivity in ATP1A3+ EVs from AD plasma, providing better diagnostic prediction of AD over other plasma biomarkers. Thus, ATP1A3 is a reliable target to isolate NDEV from biofluids for diagnostic research.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie d'Alzheimer / Vésicules extracellulaires Limites: Humans Langue: En Journal: Sci Adv Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie d'Alzheimer / Vésicules extracellulaires Limites: Humans Langue: En Journal: Sci Adv Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique